يعرض 1 - 4 نتائج من 4 نتيجة بحث عن '"Widhalm, G."', وقت الاستعلام: 0.84s تنقيح النتائج
  1. 1
    دورية أكاديمية
    418P - Markers of systemic inflammation correlate with survival prognosis in patients with newly diagnosed brain metastases.

    المؤلفون: Starzer, A.M.1 (AUTHOR), Deischinger, C.2 (AUTHOR), Steindl, A.1 (AUTHOR), Mair, M.1 (AUTHOR), Widhalm, G.3 (AUTHOR), Frischer, J.M.3 (AUTHOR), Gatterbauer, B.3 (AUTHOR), Marosi, C.1 (AUTHOR), Dieckmann, K.4 (AUTHOR), Preusser, M.1 (AUTHOR), Berghoff, A.S.1 (AUTHOR)

    المصدر: Annals of Oncology. 2019 Supplement 6, Vol. 30, pv152-v152. 1p.

    مصطلحات موضوعية: *BRAIN metastasis, *NEUTROPHIL lymphocyte ratio, *DISEASE progression, *C-reactive protein, *TUMOR diagnosis

    الشركة/الكيان: DAIICHI Sankyo Inc. , MERCK KGaA

    النص الكامل

    أضف إلى المفضلة
  2. 2
    دورية أكاديمية
    403PD - Tumour mutational burden and immune infiltrates in primary renal cell carcinoma and matched brain metastases.

    المؤلفون: Steindl, A.1 (AUTHOR), Bergen, E.S.1 (AUTHOR), Alpar, D.2 (AUTHOR), Gatterbauer, B.3 (AUTHOR), Dieckmann, K.4 (AUTHOR), Widhalm, G.3 (AUTHOR), Hainfellner, J.A.5 (AUTHOR), Schmidinger, M.1 (AUTHOR), Bock, C.2 (AUTHOR), Müllauer, L.6 (AUTHOR), Preusser, M.1 (AUTHOR), Berghoff, A.S.1 (AUTHOR)

    المصدر: Annals of Oncology. 2019 Supplement 6, Vol. 30, pv148-v148. 1p.

    مصطلحات موضوعية: *RENAL cell carcinoma, *BRAIN metastasis, *TUMOR-infiltrating immune cells, *IMMUNE checkpoint proteins, *IMMUNE checkpoint inhibitors

    الشركة/الكيان: DAIICHI Sankyo Inc. , MERCK KGaA

    النص الكامل

    أضف إلى المفضلة
  3. 3
    دورية أكاديمية
    402PD - Impact of neurological symptom burden on the survival prognosis in a real-life cohort of patients with non-small cell lung cancer brain metastases.

    المؤلفون: Steindl, A.1 (AUTHOR), Yadavalli, S.2 (AUTHOR), Gruber, K.A.1 (AUTHOR), Seiwald, M.1 (AUTHOR), Frischer, J.M.3 (AUTHOR), Gatterbauer, B.3 (AUTHOR), Dieckmann, K.4 (AUTHOR), Marosi, C.1 (AUTHOR), Widhalm, G.5 (AUTHOR), Preusser, M.1 (AUTHOR), Berghoff, A.S.1 (AUTHOR)

    المصدر: Annals of Oncology. 2019 Supplement 6, Vol. 30, pv148-v148. 1p.

    مصطلحات موضوعية: *VERTIGO, *NON-small-cell lung carcinoma, *BRAIN cancer, *BRAIN metastasis, *PROGNOSIS, *OVERALL survival

    الشركة/الكيان: DAIICHI Sankyo Inc. , MERCK KGaA

    النص الكامل

    أضف إلى المفضلة
  4. 4
    دورية أكاديمية
    395PD - Circulating PD-L1 levels vary across brain tumour entities and are oppositely linked to survival in glioblastoma and lower grade glioma patients.

    المؤلفون: Mair, M.1 (AUTHOR), Ilhan-Mutlu, A.1 (AUTHOR), Pajenda, S.2 (AUTHOR), Widhalm, G.3 (AUTHOR), Dieckmann, K.4 (AUTHOR), Hainfellner, J.A.5 (AUTHOR), Marosi, C.1 (AUTHOR), Wagner, L.2 (AUTHOR), Preusser, M.1 (AUTHOR), Berghoff, A.S.1 (AUTHOR)

    المصدر: Annals of Oncology. 2019 Supplement 6, Vol. 30, pv145-v145. 1p.

    مصطلحات موضوعية: *BRAIN tumors, *SECONDARY primary cancer, *GLIOMAS, *GLIOBLASTOMA multiforme, *CELL receptors, *PROGRAMMED death-ligand 1

    الشركة/الكيان: DAIICHI Sankyo Inc.

    النص الكامل

    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS — أرسل هذا البحث بالبريد الإلكتروني — حفظ البحث